Holly Harper

Holly Harper

Auto-generated profile, based on publicly available information

Holly Harper

Department of Pathology, Case Western Reserve University, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in JCO Clinical Cancer Informatics
Verified
Journal Article
Open access
PLPatrick Leo
Patrick Leo
BNBehtash Nezami
Behtash Nezami
MAMahmut Akgul
Mahmut Akgul
NTNaoto Tokuyama
Naoto Tokuyama
XFXavier Farré
Xavier Farré
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
PURPOSE: Current risk assessment tools for bladder cancer following transurethral resection of the bladder tumor (TURBT) depend on pathological examination of resected tissue, with the consequent intra- and inter-reviewer variability. Improved prognostic tools could enable increased monitoring and aggressive interventions for high-risk patients while reducing the frequency of invasive testing for low-risk patients. METHODS: We present an automated tumor risk assessment method based on quantitative features of nuclear pleomorphism and polarity extracted from digitized hematoxylin and eosin slides and compared this model with pathologist grading. Our model, incorporating six features, was trained to estimate overall survival risk on n = 189 patients and validated for recurrence prognosis on an independent validation set of n = 151 patients. RESULTS: The model had an accuracy of 0.73 (95% CI, 0.66 to 0.81) in identifying patients who would have recurrence within 5 years of surgery. Within the validation set was a consensus set of patients (n = 94) on which three pathologists independently assigned the same grade and a nonconsensus set (n = 57) where they did not. The model had similar performance in the consensus and nonconsensus set, with accuracies of 0.70 (95% CI, 0.61 to 0.80) and 0.78 (95% CI, 0.67 to 0.89), respectively, and was able to recapitulate pathologist scoring on the consensus set (accuracy = 0.76). CONCLUSION: The results of this study suggest the need to incorporate both computerized analysis and pathologist grading into post-TURBT treatment planning.

1 April 2026 in Radiology
Verified
Journal Article
Closed access
DFDheeman Futela
Dheeman Futela
ZYZhiqing Yin
Zhiqing Yin
SMSohrab Afshari Mirak
Sohrab Afshari Mirak
SRSeth Ryan
Seth Ryan
HHHolly Harper
Holly Harper
STSree Harsha Tirumani
Sree Harsha Tirumani
Quantitative MRI evaluation of prostate lesions using rapid, B 1 -insensitive prostate MR fingerprinting and apparent diffusion coefficient mapping differentiated clinically significant cancers from clinically insignificant lesions.

1 March 2026 in Radiology
Verified
Journal Article
Open access
STSree Harsha Tirumani
Sree Harsha Tirumani
CMChristina J. MacAskill
Christina J. MacAskill
YSYilun Sun
Yilun Sun
DFDheeman Futela
Dheeman Futela
HHHolly Harper
Holly Harper
YCYong Chen
Yong Chen
Kidney T1 and T2 relaxation times extracted from MR fingerprinting provided complementary information for noninvasive differentiation of indolent versus aggressive renal neoplasms.